OBJECTIVE: To quantify the effects of fasting lipids, age, apolipoprotein (apo) E polymorphism, insulin resistance, body fat and abdominal fat distribution, on postprandial lipemia (PPL) in non-diabetic obese women. DESIGN: Cross-sectional, prospective. SUBJECTS: A total of 93 obese women (meanAE AEs.d. age 39AE AE13 y; body mass index (BMI) 38.3AE AE4.9 kga am 2 ) and 16 nonobese women (25AE AE8 y; BMI 22.7AE AE3.2 kga am 2 ). MEASUREMENTS: Body fat distribution was determined by the ratio of waist-to-hip circumferences (WHR) and by computed tomography (CT) at the L4-L5 level. Apo E genotyping was performed by restriction isotyping. Insulin resistance was calculated from fasting glucose and insulin concentrations. PPL was evaluated using the vitamin A-fat tolerance test (1.0 g fata akg body weight and 7.0 mg cholesterola akg body weight 300 000 IU vitamin A palmitate). Blood samples were drawn before, and every 1.5 h for 7.5 h plus 24 h after ingestion of the fat meal. Areas under the response curves (AUC) for triglycerides (TG) and retinyl palmitate (RP) were calculated using the geometrical method for two time intervals, that is, 0 ± 7.5 h and 0 ± 24 h. RESULTS: Incremental AUCs TG, but not AUCs RP, were increased in the obese women. Apo E polymorphism, BMI, WHR and menopausal state did not in¯uence PPL in the obese women. Fasting TG, age, the intra-abdominal to subcutaneous abdominal fat ratio (IAa aSC ratio) and insulin resistance were independent determinants of PPL. Together, fasting TG, IAa aSC ratio and insulin resistance, explained 38% of the variance in AUC TG 0 ± 7.5 h (P 0.0001). CONCLUSION: Alterations in PPL are to be added to the increasing number of components of the plurimetabolic syndrome.
Introduction
The remarkable metabolic heterogeneity among obese patients is related to differences in regional body fat distribution, rather than to the amount of total body fat. 1 ± 3 Prospective studies have shown that abdominal adiposity is associated with coronary heart disease risk in both women 1 and men. 2 In most studies, regional body fat distribution was assessed by the ratio of waist to hip circumference (WHR). Technological advances such as computed tomography (CT) now provide more precise measurements of body fat distribution, including the differentiation between intra-abdominal (IA) and subcutaneous (SC) adipose tissue. 4 The use of CT has established that the amount of visceral fat is a major determinant of the metabolic complications observed in abdominal obesity. 5 However, signi®cant residual metabolic heterogeneity persists among obese patients with similar amounts of visceral fat. 3 Genes involved in lipoprotein metabolism may modulate the effect of body fat distribution on plasma lipoprotein levels. Pouliot et al 6 have reported that apolipoprotein (apo) E polymorphism alters the relationship between visceral obesity and fasting lipoproteins in obese women (body mass index, BMI 28 ± 33 kgam 2 ). In women homozygous for apo E3, visceral fat was positively related to both very low density lipoprotein (VLDL) and low density lipoprotein (LDL) lipids, while in apo E2 carriers, visceral fat was predominantly associated with VLDL lipids and only weakly with LDL-triglycerides. No association was found between deep abdominal fat and VLDL in apo E4 carriers. In addition, Uusitupa et al 7 have observed that women with the apo E2a3 phenotype are least susceptible and those with the apo E4 allele are most susceptible to hyperinsulinemia and elevation of blood pressure found in central obesity.
Most studies about the effects of body fat distribution on lipoprotein metabolism, have considered only fasting blood lipids and lipoproteins. 5,8 ± 10 However, as ®rst proposed by Zilversmit 11 and more recently by Patsch, 12 postprandial hyperlipemia may be particularly atherogenic, especially since a major part of a lifetime is spent in the period between food ingestion and 6 ± 8 h thereafter. Accumulating evidence suggests that postprandial lipemia (PPL) is an independent predictor of coronary and carotid atherosclerosis. 13 ± 16 We have therefore evaluated PPL in a large group of obese women with a wide range of adiposity to further de®ne the pro®le of the`obese patient at risk'. The purpose of this study was to investigate the effects on PPL of 1) apo E polymorphism; 2) age, BMI, WHR, and abdominal fat distribution; and 3) hyperinsulinemiaainsulin resistance in non-diabetic obese women.
Subjects and methods

Subjects
A total of 93 obese women, aged 18 ± 64 y (mean AE s.d. 39 AE 13 y), with a BMI of 28.5 ± 50.4 kgam 2 ) were studied. All subjects had a stable body weight for several months before the study and, except for being obese, were judged to be in good health according to their medical history and physical examination. All women had normal fasting glycemia, normal kidney function and were euthyroid. No subject was using any medication known to affect lipoprotein metabolism. Among the obese women, 19 were postmenopausal. They did not receive hormonal substitution. Data were also obtained on 16 healthy, normolipidemic nonobese women (mean age 25AE 8 y; BMI 22.7 AE 3.2 kgam 2 ). All participants gave informed consent to the study protocol, which was approved by the Ethical Committee, University Hospital Gasthuisberg, Leuven, Belgium.
Anthropometry
Body composition was evaluated by bioelectrical impedance (RJL Systems) using the formula described by Deurenberg et al. 17 Body fat distribution was determined by anthropometric WHR and by CT at the L4-L5 level. To determine WHR, the waist circumference was assessed as the minimal abdominal girth and the hip circumference was measured at the level of the greater trochanters. All measurements were made by the same person to the nearest 0.5 cm using a nonelastic tape. Mean values of duplicate measurements were used in the calculations. CT was performed with a Somaton Plus-S Siemens instrument. The subjects were examined in the supine position. The total and IA fat areas were calculated by delineating these areas with a graph pen and then computing the adipose tissue surfaces with an attenuation interval of 750 to 7150 HU. The IA fat area was measured by drawing a line within the muscle wall surrounding the abdominal cavity. SC fat was calculated by subtracting the amount of IA fat from the total fat area. IA and SC abdominal fat areas were used to calculate the ratio IA to SC fat (IAaSC ratio).
Fasting lipids and lipoproteins
Serum levels of total cholesterol (CV 1.4%) were determined enzymatically using a CHOD-PAP (cholesterol oxidase-phenol-4-amino phenazone) kit from Boehringer Mannheim, Germany. HDL-cholesterol (CV 4.0%) was determined after precipitation with phosphotungstate-Mg 2 . Triglycerides (TG; CV 2.0%) were measured enzymatically using a glycerol phosphate oxidase-phenol 4-amino phenazone (GPO-PAP) kit from Boehringer Mannheim. Apo A 1 (CV 5.0%) and B (CV 1.5%) were assayed by immunonephelometry with kits from Boehringer Mannheim. Plasma glucose (CV 2.9%) was measured using the hexokinaseaG6P-DH UV method of Boehringer Mannheim. HbA 1c was determined by HPLC (normal range: 3.6 ± 6.4; CV 4.0%) and insulin was measured by radioimmunoassay (RIA). Apo E genotyping was performed by polymerase chain reaction (PCR).
18
Vitamin A-fat tolerance test
The magnitude of PPL was evaluated using the vitamin A-fat tolerance test. After a 14 h overnight fast, subjects were given a fat meal, containing 1.0 g fatakg body weight and 7.0 mg cholesterolakg. 19 Meals contained 53.0 En% fat, 23.5 En% protein and 23.5 En% carbohydrate, and consisted of bread, butter, cheese, meat, cream, egg, sugar, milk and Protifar (Nutricia, The Netherlands). Vitamin A palmitate 300 000 IU (Merck, Darmstadt, Germany) was added to the meal to label the intestinally derived particles with retinyl esters. Although we recognize the limitations of retinyl esters as speci®c markers of chylo-micron remnants, 20, 21 retinyl palmitate (RP) levels serve as useful estimates of the intestinally derived component of PPL. 22, 23 RP was determined by HPLC.
24 RP (Merck) was added to the samples as an internal standard and pyrogallol (Merck) was added to protect against oxidation. Interassay CV for RP was 9.3%. Blood samples were drawn prior to the test meal and at 1.5 h, 3 h, 4.5 h, 6 h, 7.5 and 24 h. Only water was allowed during the ®rst 7.5 h. Subjects were given a very-low-calorie meal (153 kcala638 kJ; 17 g protein, 15 g carbohydrate, and 2.3 g fat; 1000 IU vitamin A) (Modifast, Sandoz Nutrition, Belgium) 9 h after the start of the test.
The areas under the response curve (AUC) for TG or RP were calculated using the geometrical method, as described by Wolever and Jenkins. 25 Any area below the fasting level was ignored. AUCs were calculated for two time intervals, that is, 0 ± 7.5 h and 0 ± 24 h. The postprandial response to the test meal was also evaluated by means of the postprandial increase and the time to peak, as described by Brown and Roberts. 26 The following equations were used:
time to peak h X max X 2nd a2X
Insulin resistance
Insulin resistance and b-cell function were calculated using the homeostasis model of Matthews et al, 27 that assumes 100% b-cell function and an insulin 2 ) are presented in Figure 1 , Figure 2 and in Table 1 . As a group, the obese women had a signi®cantly less favourable fasting lipid pro®le than the nonobese controls, although most obese women were normolipidemic. Both the incremental AUC TG 0 ± 7.5 h and AUC TG 0 ± 24 h were signi®cantly different between the obese and nonobese women. Individual measurement points were signi®cantly (P`0.01) higher in the obese group. AUC RP was not different between obese and nonobese women. The nonobese women had higher (P`0.01) plasma RP concentrations at 1.5 h and 3 h after the meal.
Among the 93 obese subjects, 57 (61%) had the E3a3 genotype, 14 (15%) had the E2a3 genotype and 22 (24%) had the E3a4 genotype. No signi®cant differences were observed among the three apo E genotypic groups in anthropometric characteristics, in fasting lipid and apolipoprotein concentrations, or in postprandial TG and RP responses to the vitamin A-fat meal (Table 2, Figure 3 and Figure 4 ). Since apo E polymorphism did not in¯uence PPL in these obese women, the effects of the anthropometric and metabolic variables on PPL were subsequently evaluated for the entire group of obese women.
Simple Pearson correlation coef®cients were calculated to examine the effects of fasting TG, age, BMI and indices of body fat distribution on fasting and postprandial variables ( Table 3) . As expected, fasting TG was positively related to the magnitude of PPL. Similar relationships were observed with age. Division of the study group into premenopausal (n 74) or postmenopausal (n 19) women did not, however, result in signi®cant differences in fasting lipids or PPL according to menopausal state, despite a signi®cantly higher IAaSC ratio in postmenopausal women (0.23AE 0.12 and 0.36AE 0.13 in pre-and postmenopausal subjects, respectively; P 0.001). BMI was positively correlated with fasting TG, but not with PPL. No relationship was observed between WHR and fasting or postprandial lipids. The IAaSC abdominal fat ratio related signi®cantly with fasting cholesterol and apo B, and with both AUC TG and AUC RP.
Most of the obese women included in this study were insulin resistant, as assessed from fasting glucose and insulin values by the homeostasis model of Matthews et al 27 (Table 4) . Simple Pearson correlation coef®cients between parameters of carbohydrate and lipid metabolism are presented in Table 5 . Fasting HDL-cholesterol and apo A 1 were negatively related to fasting insulinemia and insulin resistance. Fasting insulin was positively associated with AUC TG 0 ± 24 h, and calculated insulin resistance correlated with both 0 ± 7.5 h and 0 ± 24 h AUC TG. A stepwise multiple regression analysis (Table 6 ) was subsequently used to further quantify the effects of fasting TG, age, insulin resistance and IAaSC ratio on fasting and postprandial parameters. Age and fasting TG were independent determinants of fasting cholesterol and apo B, while insulin resistance in¯u-enced fasting HDL-cholesterol. In addition to fasting TG, IAaSC ratio and insulin resistance contributed signi®cantly and independently to AUC TG 0 ± 7.5 h, and age to AUC TG 0 ± 24 h. Only age and IAaSC ratio reached the level of signi®cance for AUC RP 0 ± 7.5 h and AUC RP 0 ± 24 h, respectively.
Discussion
The magnitude of PPL is in¯uenced by numerous environmental and genetic factors affecting the synthesis and catabolism of TG-rich lipoproteins originating from the liver and intestine. 20, 28 To further characterize the obese person at risk for cardiovascular diseases, we have evaluated the effects of potential Table 1 Fasting and postprandial lipids and lipoproteins in control women (n 16) and obese women (n 93).
Controls
Obese P 29, 30 AUC TG 0 ± 8 h was signi®cantly greater in obese men with abdominal fat patterning, as assessed by WHR, compared to normal-weight men. 29 Our results con®rm previous data from Lewis et al 30 in seven normolipidemic, severely obese subjects, who had higher TG levels and similar RP concentrations in response to a vitamin A-fat meal compared to lean controls. The fact that in both studies only the postprandial TG levels differ signi®cantly between lean and obese subjects suggests that a signi®cant portion of their postprandial TG response is due to endogenous hepatic lipoproteins. An increase in the in¯ux of exogenous TG-rich lipoproteins into the plasma inhibits the clearance of TG-rich lipoproteins of endogenous origin. 31, 32 A higher fat content of the test meal accentuates the degree of PPL. 32 The amount of fat received by our subjects was adapted to their body mass. The absolute amount of fat in the test meal of the obese women was therefore higher. This may partly explain the overall difference in response between lean and obese women. In contrast to the results of Lewis et al, 30 the time to reach the peak value for both TG and RP was signi®cantly delayed in the obese women. This suggests a difference in the rate of gastric emptying between obese and lean women, since meal size and fat content are predictors of the rate of gastric emptying in the obese. 33, 34 Apo E polymorphism is an important determinant of receptor-mediated clearance of remnant particles. 35 It has been reported to in¯uence the relationships of body fatness and abdominal fat accumulation to fasting plasma lipoproteins, insulin levels and blood pressure in obese women. 6, 7 Previously, we were however unable to observe a signi®cant effect of apo E polymorphism on fasting lipid concentrations of 54 obese women when the effects of age, BMI, WHR and fat-free mass were included in the model. 36 In accordance with our earlier data, fasting lipid levels 39 Other investigators did, however, not observe an effect of apo E on AUC RP. 23, 26 Apo E polymorphism has consistently been shown not to in¯uence AUC TG in normal-weight individuals. 23,26,37 ± 40 To our knowledge, no previous study has evaluated the effect of apo E genotype on PPL in the obese. In our sample, no effect of apo E polymorphism was found on postprandial RP or TG concentrations.
It is well recognized that the magnitude of PPL increases with age 19, 41 and with rising fasting TG. 13, 19, 23, 26, 30, 32, 40, 41 In the present study, both age and fasting TG were predictors of PPL in obese women. In addition, we have observed that the IAaSC ratio and insulin resistance were independent determinants of PPL. Together, fasting TG, IAaSC ratio and insulin resistance predicted 38% of AUC TG 0 ± 7.5 h. Body fatness, as measured by BMI, and WHR did not in¯uence PPL. The relationships of BMI and IA fat to PPL have previously been evaluated in only one study of 29 middle-aged, normalweight men and women. 41 IA fat, but not BMI or WHR, correlated strongly and independently with the postprandial TG response (r 0.52). The analysis did, however, not take into account the potential contributions of SC fat or of the IAaSC fat ratio. The independent contributions of the IAaSC fat ratio and insulin resistance to PPL in obese women, that were observed in the present study, are in agreement with recent in vivo and in vitro data, which suggest that an altered balance in free fatty acid (FFA) release from visceral vs SC adipose tissue may be an important pathophysiological factor behind the metabolic complications in upper-body obesity. 42 ± 46 The rate of lipolysis is higher in visceral than in SC adipose tissue. In upper-body obesity, these site differences are further enhanced. Lipolysis resistance is observed in SC fat cells due to a change in b 2 -and a 2 -adrenoceptor function in combination with impaired function of hormone-sensitive lipase. 43, 45 In contrast, lipolysis is enhanced in visceral fat cells, mainly due to increased adipocyte b 3 -adrenoceptor function. 47 These changes promote FFA release from the visceral depot to the liver by the portal system, which in turn can increase TG production. 46 The antilypolytic effect of a mixed meal is reduced in upper-body obese women. 42 Failure to suppress the supply of FFA after a meal, which is closely linked to insulin resistance, 48 may lead to sustained VLDL production in the postprandial period. In the insulin-resistant state, VLDL overproduction is compounded by failure of postprandial activation of lipoprotein lipase and by the competition between exogenous and endogenous TG-rich particles for the same lipolytic pathway. 49, 50 These mechanisms may explain the important role of insulin resistance in regulating the postprandial concentration of TG-rich lipoproteins, including those of intestinal origin. 51 They are also in agreement with the positive relationship between insulin resistance and postprandial TG in our study sample, that consisted mainly of abdominally obese, insulin-resistant women. Our results demonstrate that alterations in PPL, that have previously been shown to be an independent risk factor for cardiovascular disease, are to be added to the increasing number of components of the plurimetabolic syndrome (syndrome X). 52 
Conclusion
Postprandial TG levels, but not RP concentrations, are elevated in obese women compared to lean controls. ApoE polymorphism, menopausal state, total body fatness and WHR, do not correlate with PPL. In addition to fasting TG, age, insulin resistance and the IAaSC ratio are positive and independent determinants of PPL.
